Blood Glucose Detected Through Photoacoustics
Researchers have developed a non-invasive photoacoustic sensing technique to measure blood glucose levels.
Researchers have developed a non-invasive photoacoustic sensing technique to measure blood glucose levels.
Thanks to male fertility testing research, a new POC test has been developed that will allow rapid diagnosis of stroke or concussion.
At-home fertility testing is joining an array of routine tests that will be done increasingly at home, will impact clinical labs.
The FDA CLIA-waived handheld analyzer reliably and efficiently delivers results within just 5 to 10 seconds, and it can be used in point-of-care (POC) and certificate of waiver settings, such as physicians’ offices, clinics, and other nontraditional laboratory locations.
Read MoreThe app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read MoreSpeeDx and the QuantuMDx Group are collaborating with the Foundation for Innovative New Diagnostics to assess the feasibility of developing low-cost, point-of-care tests for common sexually transmitted infections.
Read MoreThe assay is intended to help stop the spread and transmission of carbapenem-producing organisms.
Read MoreQuo-Lab meets strict international quality targets, confirming its fit for purpose in diabetes testing.
Read MoreThe study found that using POC tests as a replacement for laboratory tests resulted in earlier decisionmaking in approximately 75% of cases across three UK hospital sites.
Read MorePOC testing is unlocking new markets for commercial IVDs, but reaching potential new customers can be a challenge.
Read MoreCinical laboratorians are likely to remain an important part of the process for selecting, adopting, managing, and performing POC testing.
Read MoreThis month’s issue features point-of-care assays and analyzers from such companies as BioFire Diagnostics, EKF Diagnostics, and Roche Diagnostics.
Read MoreWith connectivity, point-of-care testing is on the front line when it comes to diagnosing and managing chronic diseases.
Read MoreRelaymed’s secure, cloud-based service will connect Siemens POC instruments to physician-office electronic health record systems, reducing the potential for errors and revenue loss.
Read MoreThe device is the first of the company’s Alinity family of diagnostic instruments to launch.
Read MoreThe company has launched its next-generation wireless rapid diagnostic system for detection of group A Strep, influenza A and B, and respiratory syncytial virus.
Read MoreThis month’s issue features point-of-care assays and analyzers from such companies as Alere, Chembio, and Siemens Healthineers.
Read MoreUrinalysis instruments offer expanding feature sets designed to meet diverse testing requirements.
Read More